DAVID KRUEGER: Open Payments
NPI 1730294620 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,194 in 93 payments from 30 companies in 2025. Trend: 2023 $1,610 · 2024 $2,128 · 2025 $2,194
Food & beverage: $2,194
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $450 |
| ABBVIE INC. | 13 | $180 |
| Biogen, Inc. | 3 | $153 |
| Neurocrine BioSciences, Inc. | 4 | $122 |
| Alexion Pharmaceuticals, Inc. | 4 | $117 |
| Teva Pharmaceuticals USA, Inc. | 5 | $116 |
| Eisai Inc. | 4 | $100 |
| GE HEALTHCARE | 4 | $89 |
| Lundbeck LLC | 4 | $86 |
| ARGENX US, INC. | 4 | $83 |
Products named: Fintepla, VUMERITY, INGREZZA, ULTOMIRIS, AUSTEDO XR, Leqembi, VYALEV, VYEPTI.
Industry payments across FL — which companies pay providers there.
